Events

Alerta De Seguridad para cholesterol, CHOD‐PAP

Según National Institute of Drugs and Food Surveillance (INVIMA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Colombia que fue producido por manufacturer #121.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    IRD-010815
  • Número del evento
    2010RD-0001816
  • Fecha
    2015-07-27
  • País del evento
    Colombia
  • Fuente del evento
    INVIMA
  • URL de la fuente del evento
    https://app.invima.gov.co/alertas/dispositivos-medicos-invima?page=176
  • Notas / Alertas
    Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
  • Notas adicionales en la data
  • Causa
    Interferences of the drugs n-acetylcysteine (nac), acetaminophen and metamizole, administered to patients in therapeutic encounters, in the measurement of analytes based on the so-called trinder reactions. the reactions used a colorimetric reaction between trinder peroxide dehydrogen (h2o2), a phenolic derivative, and amino-antipyrine in the presence of peroxidase, which is catalyzed, reaction interrupted by the drugs mentioned above. dialab states that while this information is updated in the precautions of the insert of the product, these analyzes should be done before the administration of these drugs.

Device

cholesterol, CHOD‐PAP
  • Modelo / Serial
    Cholesterol, CHOD‐PAP Cholesterol HDL Direct, immunoinhibitionCholesterol LDL Direct, enzymatic selective protectionCreatinine, enzymatic, PAPGlucose, GOD‐PAPNEFA, ACOD‐PAPTriglycerides, GPO‐PAPUric Acid TBHBA, enzymatic colorimetricUric Acid AOX, enzymatic colorimetric
  • Descripción del producto
    Determination of related analytes in samples from the human organism
  • Manufacturer
    manufacturer #121

Manufacturer

manufacturer #121
  • Empresa matriz del fabricante (2017)
    Abbott Laboratories
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NIDFSINVIMA